Antibody-drug conjugate (ADC) loaded with a pan-ras inhibitor

TW202637224APending Publication Date: 2026-09-16ADLAI NORTYE BIOPHARMA CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114149013
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-22
Filing Date
2025-12-12
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076746_001
    Figure TWG2TA001076746_001
  • Figure TWG2TA001076746_002
    Figure TWG2TA001076746_002
  • Figure TWG2TA001076746_003
    Figure TWG2TA001076746_003
Patent Text Reader

Abstract

An antibody-drug conjugate (ADC) loaded with a pan-RAS inhibitor, characterized by the innovative use of a pan-RAS inhibitor as the bioactive payload. The ADC of the present invention exhibits high anti-tumor activity, effectively kills tumor cells, and possesses a bystander killing effect.
Need to check novelty before this filing date? Find Prior Art